Abivax (ABVX) Interest Coverage Ratio (2024 - 2026)
Abivax's (ABVX) quarterly Interest Coverage Ratio came in at 11.79 in Q1 2026, up 67.94% year-on-year from 7.02 in Q1 2025, and down 90.74% quarter-over-quarter from 127.34 in Q4 2025.
Abivax (ABVX) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Abivax's Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 11.79 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 67.94% year-over-year to 11.79 in Q1 2026; TTM through Mar 2026 was 2.45, a 99.89% decrease from a year earlier, with the FY2025 full-year figure at 2.2, up 78.37% from the prior year.
- Interest Coverage Ratio fell to 11.79 in Q1 2026 per ABVX's latest filing, from 127.34 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 127.34 in Q4 2025 and bottomed at 1.92 in Q4 2024.
- The 3-year median for Interest Coverage Ratio is 7.02 (2025), against an average of 19.47.
- Biggest YoY gain for Interest Coverage Ratio was 6749.01% in 2025; the steepest drop was 85.35% in 2025.
- Year by year, Interest Coverage Ratio stood at 1.92 in 2024, then surged by 6749.01% to 127.34 in 2025, then sank by 90.74% to 11.79 in 2026.
- Per Business Quant, the three latest ABVX Interest Coverage Ratio figures stand at 11.79 (Q1 2026), 127.34 (Q4 2025), and 0.87 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 11.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.79 |
| Dec 31, 2025 | 127.34 |
| Sep 30, 2025 | 0.87 |
| Jun 30, 2025 | 8.59 |
| Mar 31, 2025 | 7.02 |
| Dec 31, 2024 | -1.92 |
| Sep 30, 2024 | 5.92 |
| Jun 30, 2024 | 5.01 |
| Mar 31, 2024 | 10.57 |